Innovative healthcare investment opportunity Looking for an innovative healthcare product investment opportunity? Check out FendX Technologies (FNDX.c) and its award-winning nanotechnology designed to combat the spread of viruses and promote public health.
Uniquely positioned to take advantage of the surface coating market, estimated to hit US$3.5 billion by 2025, growing from US$1.3 billion in 2020 at an 18% CAGR, FNDX's RepelWrap is a first-of-its-kind coating product with patent-pending and proprietary technology.
RepelWrap's unique repelling properties prevent the adhesion of pathogens, bacteria and viruses, reducing their transmission on surfaces prone to contamination.
The nanotechnology causes both high and low surface tension liquids to form droplets when they come in contact with the nano-surface to prevent adhesion on high contact touch points, and is expected to have numerous applications and opportunities in healthcare and beyond.
Following the events of the pandemic, he need for a more effective solution to reduce the rate of infection and the spread of germs, bacteria, viruses and pathogens is clear and FNDX's RepelWrap can provide an essential line of defense in various settings such as hospitals, schools, and public transportation.
Notably, FNDX recently hit an important milestone with the engagement Dunmore for the scale-up development of its RepelWrap which is the first step to assessing and creating an automated manufacturing process, positioning FNDX for significant revenue generation once in commercial production which is expected in 2024.
For more information, check out this deep dive DD packet: https://www.reddit.com/r/PennyStocksCanada/comments/11qhnvo/fendx_technologies_due_diligence_packet_a/
Posted on behalf of FendX Technologies Inc.